| review article | Q7318358 |
| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1084251893 |
| P356 | DOI | 10.1186/S13045-017-0436-9 |
| P932 | PMC publication ID | 5345270 |
| P698 | PubMed publication ID | 28279189 |
| P50 | author | Go J Yoshida | Q55755092 |
| P2093 | author name string | Go J Yoshida | |
| P2860 | cites work | Spread of artemisinin resistance in Plasmodium falciparum malaria | Q21032481 |
| Protection against fatal Sindbis virus encephalitis by beclin, a novel Bcl-2-interacting protein | Q22003920 | ||
| Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition) | Q22676705 | ||
| CD44 variant regulates redox status in cancer cells by stabilizing the xCT subunit of system xc(-) and thereby promotes tumor growth | Q24296787 | ||
| p62/SQSTM1 binds directly to Atg8/LC3 to facilitate degradation of ubiquitinated protein aggregates by autophagy | Q24312147 | ||
| Autophagosomes form at ER-mitochondria contact sites | Q24322618 | ||
| Metabolic activation-related CD147-CD98 complex | Q24539137 | ||
| Autophagy, mitochondria and oxidative stress: cross-talk and redox signalling | Q24608960 | ||
| The AMPK signalling pathway coordinates cell growth, autophagy and metabolism | Q24616273 | ||
| Promotion of tumorigenesis by heterozygous disruption of the beclin 1 autophagy gene | Q24617547 | ||
| mTOR: from growth signal integration to cancer, diabetes and ageing | Q24633662 | ||
| Autophagy suppresses tumorigenesis through elimination of p62 | Q24650670 | ||
| Therapeutic strategies targeting cancer stem cells | Q26781398 | ||
| Metabolic reprogramming: the emerging concept and associated therapeutic strategies | Q26786595 | ||
| Cancer metabolic reprogramming: importance, main features, and potentials for precise targeted anti-cancer therapies | Q26823118 | ||
| The emerging role of acetylation in the regulation of autophagy | Q26829365 | ||
| DNA damage repair pathways in cancer stem cells | Q26859012 | ||
| Mitophagy: mechanisms, pathophysiological roles, and analysis | Q26865743 | ||
| Circulating tumour cells: the evolving concept and the inadequacy of their enrichment by EpCAM-based methodology for basic and clinical cancer research | Q27024191 | ||
| Status of PI3K/Akt/mTOR pathway inhibitors in lymphoma | Q27026544 | ||
| Impact of metabolic heterogeneity on tumor growth, invasion, and treatment outcomes. | Q27348042 | ||
| Temozolomide promotes genomic and phenotypic changes in glioblastoma cells. | Q36875981 | ||
| Combination therapy for rheumatoid arthritis: methotrexate and sulfasalazine together or with other DMARDs | Q36897036 | ||
| Physiological functions of Atg6/Beclin 1: a unique autophagy-related protein | Q36950921 | ||
| Histone deacetylase inhibitor potentiated the ability of MTOR inhibitor to induce autophagic cell death in Burkitt leukemia/lymphoma | Q37042173 | ||
| Caveolin-1-/- null mammary stromal fibroblasts share characteristics with human breast cancer-associated fibroblasts | Q37150735 | ||
| Repositioning HIV protease inhibitors as cancer therapeutics | Q37192579 | ||
| Temozolomide and cisplatin in relapsed/refractory acute leukemia | Q37223615 | ||
| Reactivation of mutant p53 by capsaicin, the major constituent of peppers | Q37233582 | ||
| New derivatives of the antimalarial drug Pyrimethamine in the control of melanoma tumor growth: an in vitro and in vivo study. | Q37237139 | ||
| AMP-activated protein kinase and human cancer: cancer metabolism revisited | Q37249341 | ||
| Autophagy and chemotherapy resistance: a promising therapeutic target for cancer treatment | Q37299613 | ||
| Sulforaphane inhibits growth of phenotypically different breast cancer cells | Q37321702 | ||
| The double-edged sword of autophagy modulation in cancer | Q37331327 | ||
| Myc inhibition impairs autophagosome formation. | Q37346986 | ||
| Transcriptional control of autophagy-lysosome function drives pancreatic cancer metabolism | Q37378754 | ||
| The phosphoinositide 3-kinase pathway in human cancer: genetic alterations and therapeutic implications. | Q37454384 | ||
| New clinical developments in histone deacetylase inhibitors for epigenetic therapy of cancer | Q37503780 | ||
| The activation of c-Jun NH₂-terminal kinase is required for dihydroartemisinin-induced autophagy in pancreatic cancer cells | Q37514559 | ||
| Autophagic cell death and cancer | Q37645404 | ||
| Mechanisms of cross-talk between the ubiquitin-proteasome and autophagy-lysosome systems | Q37664227 | ||
| xCT inhibition depletes CD44v-expressing tumor cells that are resistant to EGFR-targeted therapy in head and neck squamous cell carcinoma. | Q53124668 | ||
| Bafilomycin A1, a specific inhibitor of vacuolar-type H(+)-ATPase, inhibits acidification and protein degradation in lysosomes of cultured cells | Q67902824 | ||
| Evaporative light-scattering analysis of sulforaphane in broccoli samples: Quality of broccoli products regarding sulforaphane contents | Q82992214 | ||
| Dynamic and transient cancer stem cells nurture melanoma | Q84543414 | ||
| ROS-induced mitochondrial depolarization initiates PARK2/PARKIN-dependent mitochondrial degradation by autophagy | Q84788113 | ||
| Location and membrane sources for autophagosome formation - from ER-mitochondria contact sites to Golgi-endosome-derived carriers | Q86619100 | ||
| Heterogeneity of glycolysis in cancers and therapeutic opportunities | Q27693375 | ||
| Apg14p and Apg6/Vps30p form a protein complex essential for autophagy in the yeast, Saccharomyces cerevisiae | Q27940093 | ||
| Targeting autophagy to sensitive glioma to temozolomide treatment | Q28066270 | ||
| Glioblastoma, hypoxia and autophagy: a survival-prone 'ménage-à-trois' | Q28067399 | ||
| Imaging metabolic heterogeneity in cancer | Q28076500 | ||
| Capsaicin receptor: TRPV1 a promiscuous TRP channel | Q28282881 | ||
| Caveolin-1 is down-regulated in human ovarian carcinoma and acts as a candidate tumor suppressor gene | Q28363368 | ||
| The Keap1-Nrf2 pathway: Mechanisms of activation and dysregulation in cancer | Q28387975 | ||
| Molecular mechanisms of mitochondrial autophagy/mitophagy in the heart | Q28393192 | ||
| AMPK and mTOR regulate autophagy through direct phosphorylation of Ulk1 | Q28506431 | ||
| Mitochondrial autophagy is an HIF-1-dependent adaptive metabolic response to hypoxia | Q28586744 | ||
| Tumor microenvironment derived exosomes pleiotropically modulate cancer cell metabolism | Q28834389 | ||
| Methods in mammalian autophagy research | Q29547276 | ||
| AMPK: a nutrient and energy sensor that maintains energy homeostasis | Q29615410 | ||
| DRAM, a p53-induced modulator of autophagy, is critical for apoptosis | Q29616308 | ||
| Metabolic reprogramming: a cancer hallmark even warburg did not anticipate | Q29617612 | ||
| Self-eating and self-killing: crosstalk between autophagy and apoptosis | Q29617748 | ||
| Cell cycle checkpoint signaling through the ATM and ATR kinases | Q29617837 | ||
| AMP-activated/SNF1 protein kinases: conserved guardians of cellular energy | Q29618101 | ||
| Termination of autophagy and reformation of lysosomes regulated by mTOR | Q29619817 | ||
| Targeting xCT, a cystine-glutamate transporter induces apoptosis and tumor regression for KSHV/HIV-associated lymphoma | Q30409463 | ||
| Dual HER2 blockade: preclinical and clinical data | Q30941327 | ||
| A loading dose/continuous infusion schedule of fludarabine phosphate in chronic lymphocytic leukemia | Q33373509 | ||
| Gene expression signatures and response to imatinib mesylate in gastrointestinal stromal tumor | Q33654894 | ||
| Involvement of stromal p53 in tumor-stroma interactions. | Q33664889 | ||
| TP53 mutations in human cancers: origins, consequences, and clinical use | Q33685392 | ||
| Novel roles for the MiTF/TFE family of transcription factors in organelle biogenesis, nutrient sensing, and energy homeostasis | Q33756641 | ||
| Recent advances in drug repositioning for the discovery of new anticancer drugs | Q33845068 | ||
| Temozolomide and treatment of malignant glioma. | Q33983627 | ||
| DRAM links autophagy to p53 and programmed cell death | Q34000900 | ||
| Ferroptosis: an iron-dependent form of nonapoptotic cell death | Q34032093 | ||
| Regulated necrosis: the expanding network of non-apoptotic cell death pathways. | Q34039639 | ||
| Crosstalk between apoptosis and autophagy: molecular mechanisms and therapeutic strategies in cancer | Q34102626 | ||
| Autophagy: cellular and molecular mechanisms | Q34103624 | ||
| System xc⁻ cystine/glutamate antiporter: an update on molecular pharmacology and roles within the CNS. | Q34184493 | ||
| Circulating tumour cells escape from EpCAM-based detection due to epithelial-to-mesenchymal transition | Q34271512 | ||
| Integrated analysis identifies different metabolic signatures for tumor-initiating cells in a murine glioblastoma model. | Q41853906 | ||
| Synergism of EGFR and c-Met pathways, cross-talk and inhibition, in non-small cell lung cancer | Q41969702 | ||
| Autophagy-deficient mice develop multiple liver tumors | Q42099409 | ||
| DNA damage responses in cancer stem cells: Implications for cancer therapeutic strategies | Q42150992 | ||
| The heterogeneity of cancer stem-like cells at the invasive front | Q42321688 | ||
| Emerging role of epithelial-mesenchymal transition in hepatic cancer. | Q42395784 | ||
| Systematic analysis of overall survival and interactions between tumor mutations and drug treatment | Q42542251 | ||
| Chrysin enhances sensitivity of BEL-7402/ADM cells to doxorubicin by suppressing PI3K/Akt/Nrf2 and ERK/Nrf2 pathway | Q42709672 | ||
| Involvement of JNK in the regulation of autophagic cell death | Q43184303 | ||
| Molecular mechanisms of secondary imatinib resistance in patients with gastrointestinal stromal tumors | Q43204396 | ||
| CD44+ slow-cycling tumor cell expansion is triggered by cooperative actions of Wnt and prostaglandin E2 in gastric tumorigenesis | Q43211619 | ||
| Triggering of transient receptor potential vanilloid type 1 (TRPV1) by capsaicin induces Fas/CD95-mediated apoptosis of urothelial cancer cells in an ATM-dependent manner | Q45188338 | ||
| Analysis of KIT mutations in sporadic and familial gastrointestinal stromal tumors: therapeutic implications through protein modeling | Q46493673 | ||
| Dose-escalation study for the targeting of CD44v+ cancer stem cells by sulfasalazine in patients with advanced gastric cancer (EPOC1205). | Q46567504 | ||
| Medicine Nobel for research on how cells 'eat themselves'. | Q47649201 | ||
| Overexpression of caveolin-1 in hepatocellular carcinoma with metastasis and worse prognosis: correlation with vascular endothelial growth factor, microvessel density and unpaired artery. | Q47822697 | ||
| Autophagy and misfolded proteins in neurodegeneration | Q37811463 | ||
| Molecular mechanisms of the Keap1–Nrf2 pathway in stress response and cancer evolution | Q37830775 | ||
| Dihydrofolate reductase as a therapeutic target | Q37920947 | ||
| The role of autophagy in cancer: therapeutic implications | Q37924056 | ||
| Autophagy and polyglutamine diseases | Q37935233 | ||
| Regulation and function of autophagy during cell survival and cell death. | Q38015801 | ||
| Nuclear pore complex composition: a new regulator of tissue-specific and developmental functions | Q38054510 | ||
| p53 mutations in cancer | Q38069463 | ||
| Chloroquine in cancer therapy: a double-edged sword of autophagy. | Q38071618 | ||
| Autophagy as a defence against intracellular pathogens | Q38144290 | ||
| The endoplasmic reticulum-mitochondria connection: one touch, multiple functions. | Q38161252 | ||
| Targeting PI3K/Akt/mTOR Signaling in Cancer | Q38208314 | ||
| Priming cancer cells for drug resistance: role of the fibroblast niche | Q38232067 | ||
| Value of caveolin-1 in cancer progression and prognosis: Emphasis on cancer-associated fibroblasts, human cancer cells and mechanism of caveolin-1 expression (Review). | Q38247284 | ||
| Attacking c-Myc: targeted and combined therapies for cancer. | Q38262394 | ||
| mTOR: a pharmacologic target for autophagy regulation | Q38345168 | ||
| The critical role of mast cell-derived hypoxia-inducible factor-1α in human and mice melanoma growth | Q38456364 | ||
| Drug repositioning and repurposing: terminology and definitions in literature | Q38480989 | ||
| Helicobacter pylori virulence factor CagA promotes tumorigenesis of gastric cancer via multiple signaling pathways | Q38544635 | ||
| Autophagy at the crossroads of catabolism and anabolism | Q38547568 | ||
| Effective Management of Advanced Angiosarcoma by the Synergistic Combination of Propranolol and Vinblastine-based Metronomic Chemotherapy: A Bench to Bedside Study | Q38769283 | ||
| TPO-Induced Metabolic Reprogramming Drives Liver Metastasis of Colorectal Cancer CD110+ Tumor-Initiating Cells | Q38856960 | ||
| Terfenadine induces apoptosis and autophagy in melanoma cells through ROS-dependent and -independent mechanisms. | Q38863440 | ||
| Inversed relationship between CD44 variant and c-Myc due to oxidative stress-induced canonical Wnt activation. | Q39044097 | ||
| EpCAM expression in the prostate cancer makes the difference in the response to growth factors | Q39048151 | ||
| Role of TRPM2 and TRPV1 cation channels in cellular responses to radiation-induced DNA damage | Q39185673 | ||
| Reactive oxygen species-induced autophagic degradation of Helicobacter pylori CagA is specifically suppressed in cancer stem-like cells | Q39225246 | ||
| Knockdown of Nrf2 enhances autophagy induced by temozolomide in U251 human glioma cell line | Q39249121 | ||
| Distinct molecular mechanisms of acquired resistance to temozolomide in glioblastoma cells | Q39352627 | ||
| Temozolomide: mechanisms of action, repair and resistance | Q39436413 | ||
| The sensory-efferent function of capsaicin-sensitive sensory neurons | Q39631475 | ||
| Autophagy inhibition enhances sulforaphane-induced apoptosis in human breast cancer cells | Q39644675 | ||
| Terfenadine-induced apoptosis in human melanoma cells is mediated through Ca2+ homeostasis modulation and tyrosine kinase activity, independently of H1 histamine receptors. | Q40028503 | ||
| Caveolin-1 expression is associated with a basal-like phenotype in sporadic and hereditary breast cancer. | Q40303976 | ||
| Concomitant reduction of c-Myc expression and PI3K/AKT/mTOR signaling by quercetin induces a strong cytotoxic effect against Burkitt's Lymphoma. | Q40543100 | ||
| Ferroptosis is an autophagic cell death process | Q41162188 | ||
| Dual Targeting of the Autophagic Regulatory Circuitry in Gliomas with Repurposed Drugs Elicits Cell-Lethal Autophagy and Therapeutic Benefit | Q41301561 | ||
| Sulfasalazine impacts on ferroptotic cell death and alleviates the tumor microenvironment and glioma-induced brain edema | Q41667251 | ||
| Dual role of JNK1-mediated phosphorylation of Bcl-2 in autophagy and apoptosis regulation | Q41769812 | ||
| Cathepsin B launches an apoptotic exit effort upon cell death-associated disruption of lysosomes | Q41827502 | ||
| The cystine/glutamate antiporter system x(c)(-) in health and disease: from molecular mechanisms to novel therapeutic opportunities. | Q34279067 | ||
| Drug repurposing identifies a synergistic combination therapy with imatinib mesylate for gastrointestinal stromal tumor | Q34289180 | ||
| Therapeutic Targeting of Myc. | Q34373258 | ||
| The naphtosultam derivative RP 62203 (fananserin) has high affinity for the dopamine D4 receptor | Q34410594 | ||
| Recent advances in cancer therapy targeting proteins involved in DNA double-strand break repair. | Q35006842 | ||
| The reverse Warburg effect: aerobic glycolysis in cancer associated fibroblasts and the tumor stroma | Q35013613 | ||
| Role of mitochondrial inner membrane permeabilization in necrotic cell death, apoptosis, and autophagy | Q35019114 | ||
| UPR, autophagy, and mitochondria crosstalk underlies the ER stress response | Q35122358 | ||
| Metabolic reprogramming orchestrates cancer stem cell properties in nasopharyngeal carcinoma | Q35157443 | ||
| Metabolic state of glioma stem cells and nontumorigenic cells | Q35229102 | ||
| Autophagy and its effects: making sense of double-edged swords | Q35330324 | ||
| Glutamate release by primary brain tumors induces epileptic activity | Q35331983 | ||
| Synergistic anti-tumor effect of combined inhibition of EGFR and JAK/STAT3 pathways in human ovarian cancer | Q35619189 | ||
| L-type amino acid transport and cancer: targeting the mTORC1 pathway to inhibit neoplasia | Q35757977 | ||
| Histone deacetylase inhibitors induce autophagy through FOXO1-dependent pathways. | Q35852901 | ||
| Defining and measuring autophagosome flux—concept and reality | Q35853118 | ||
| Role of autophagy in histone deacetylase inhibitor-induced apoptotic and nonapoptotic cell death | Q35922012 | ||
| Molecular genetics and cellular features of TFE3 and TFEB fusion kidney cancers | Q36001179 | ||
| Inhibition of Dopamine Receptor D4 Impedes Autophagic Flux, Proliferation, and Survival of Glioblastoma Stem Cells | Q36051827 | ||
| Intracellular protein degradation: from a vague idea thru the lysosome and the ubiquitin-proteasome system and onto human diseases and drug targeting | Q36226090 | ||
| Stress induction of GRP78/BiP and its role in cancer. | Q36393494 | ||
| Chemoprotection by sulforaphane: keep one eye beyond Keap1. | Q36415068 | ||
| The nutrient-responsive transcription factor TFE3 promotes autophagy, lysosomal biogenesis, and clearance of cellular debris | Q36418450 | ||
| Drug Insight: temozolomide as a treatment for malignant glioma--impact of a recent trial | Q36577223 | ||
| Metabolic Heterogeneity in Human Lung Tumors. | Q36578111 | ||
| The role of Helicobacter pylori CagA in gastric carcinogenesis | Q36659807 | ||
| Activation of lysosomal function in the course of autophagy via mTORC1 suppression and autophagosome-lysosome fusion. | Q36739965 | ||
| Coordination of autophagosome-lysosome fusion and transport by a Klp98A-Rab14 complex in Drosophila. | Q36743953 | ||
| Dihydrofolate reductase as a target for chemotherapy in parasites | Q36754641 | ||
| GRP78 induction in cancer: therapeutic and prognostic implications. | Q36794164 | ||
| Connecting endoplasmic reticulum stress to autophagy by unfolded protein response and calcium. | Q36870862 | ||
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | autophagy | Q288322 |
| AMP-activated protein kinases | Q295240 | ||
| pathophysiology | Q1135939 | ||
| drug repositioning | Q5308921 | ||
| neoplasm | Q1216998 | ||
| cell death | Q2383867 | ||
| sequestosome 1 | Q21106590 | ||
| ferroptosis | Q24466962 | ||
| P5008 | on focus list of Wikimedia project | ScienceSource | Q55439927 |
| P304 | page(s) | 67 | |
| P577 | publication date | 2017-03-09 | |
| P1433 | published in | Journal of Hematology & Oncology | Q15724593 |
| P1476 | title | Therapeutic strategies of drug repositioning targeting autophagy to induce cancer cell death: from pathophysiology to treatment | |
| P478 | volume | 10 |
| Q90409938 | A Review of Research Progress in Multidrug-Resistance Mechanisms in Gastric Cancer |
| Q55487384 | A cytoplasmic long noncoding RNA LINC00470 as a new AKT activator to mediate glioblastoma cell autophagy. |
| Q91857825 | Activated Fibroblast Program Orchestrates Tumor Initiation and Progression; Molecular Mechanisms and the Associated Therapeutic Strategies |
| Q90429598 | Activated gastric cancer-associated fibroblasts contribute to the malignant phenotype and 5-FU resistance via paracrine action in gastric cancer |
| Q92343509 | Adapting and Surviving: Intra and Extra-Cellular Remodeling in Drug-Resistant Gastric Cancer Cells |
| Q92757674 | Anti-cancer effect of gallic acid in presence of low level laser irradiation: ROS production and induction of apoptosis and ferroptosis |
| Q58786173 | Antitumor activity of arsenite in combination with tetrandrine against human breast cancer cell line MDA-MB-231 in vitro and in vivo |
| Q92476256 | Applications of patient-derived tumor xenograft models and tumor organoids |
| Q52629230 | Autophagy Inhibition Stimulates Apoptosis in Oesophageal Squamous Cell Carcinoma Treated with Fasudil. |
| Q91387236 | Autophagy and cancer stem cells: molecular mechanisms and therapeutic applications |
| Q33821526 | Autophagy and its link to type II diabetes mellitus |
| Q98463606 | Autophagy is a pro-survival adaptive response to heat shock in bovine cumulus-oocyte complexes |
| Q90218263 | Breast cancer pathogenesis is linked to the intra-tumoral estrogen sulfotransferase (hSULT1E1) expressions regulated by cellular redox dependent Nrf-2/NFκβ interplay |
| Q92966885 | Cell death-related molecules and biomarkers for renal cell carcinoma targeted therapy |
| Q92355135 | Checkpoint kinase inhibitor AZD7762 enhance cisplatin-induced apoptosis in osteosarcoma cells |
| Q38728458 | Chemopreventive Strategies for Inflammation-Related Carcinogenesis: Current Status and Future Direction |
| Q89160748 | Comment on "Targeting AMPK, mTOR and β-Catenin by Combined Metformin and Aspirin Therapy in HCC: An Appraisal in Egyptian HCC Patients" |
| Q53682156 | Crosstalk between the Warburg effect, redox regulation and autophagy induction in tumourigenesis. |
| Q58765200 | Cyclin D1-CDK4 activity drives sensitivity to bortezomib in mantle cell lymphoma by blocking autophagy-mediated proteolysis of NOXA |
| Q55098336 | Dichloroacetate enhances the antitumor efficacy of chemotherapeutic agents via inhibiting autophagy in non-small-cell lung cancer. |
| Q58604430 | Dorsal Root Ganglion Maintains Stemness of Bone Marrow Mesenchymal Stem Cells by Enhancing Autophagy through the AMPK/mTOR Pathway in a Coculture System |
| Q91596391 | Drug resistance‑related sunitinib sequestration in autophagolysosomes of endothelial cells |
| Q55438519 | Emerging role of lipid metabolism alterations in Cancer stem cells. |
| Q97419057 | Emerging roles and the regulation of aerobic glycolysis in hepatocellular carcinoma |
| Q90576157 | Emerging roles of Myc in stem cell biology and novel tumor therapies |
| Q58724065 | Emerging roles of long non-coding RNAs in tumor metabolism |
| Q60917154 | Endoplasmic reticulum stress triggers Xanthoangelol-induced protective autophagy via activation of JNK/c-Jun Axis in hepatocellular carcinoma |
| Q41169170 | Exogenous H2S facilitating ubiquitin aggregates clearance via autophagy attenuates type 2 diabetes-induced cardiomyopathy |
| Q64103562 | Ferroptosis, a new form of cell death: opportunities and challenges in cancer |
| Q64119806 | Glucose-6-phosphate dehydrogenase blockade potentiates tyrosine kinase inhibitor effect on breast cancer cells through autophagy perturbation |
| Q92433522 | Inhibition LC3B can increase chemosensitivity of ovarian cancer cells |
| Q51733565 | Inhibition of growth and metastasis of triple-negative breast cancer targeted by Traditional Chinese Medicine Tubeimu in orthotopic mice models. |
| Q50318733 | Inhibition of thioredoxin activates mitophagy and overcomes adaptive bortezomib resistance in multiple myeloma |
| Q58773791 | KPNA2 promotes metabolic reprogramming in glioblastomas by regulation of c-myc |
| Q52590804 | Lactone Component From Ligusticum chuanxiong Alleviates Myocardial Ischemia Injury Through Inhibiting Autophagy. |
| Q92602537 | MCT1 relieves osimertinib-induced CRC suppression by promoting autophagy through the LKB1/AMPK signaling |
| Q55279288 | Meta-analysis of serum lactate dehydrogenase and prognosis for osteosarcoma. |
| Q64250371 | Metabolic characteristics revealing cell differentiation of nasopharyngeal carcinoma by combining NMR spectroscopy with Raman spectroscopy |
| Q92522555 | Metformin inhibits metastatic breast cancer progression and improves chemosensitivity by inducing vessel normalization via PDGF-B downregulation |
| Q94547415 | Molecular Insights Into Therapeutic Potential of Autophagy Modulation by Natural Products for Cancer Stem Cells |
| Q59808665 | Molecular Interactions Between Innate and Adaptive Immune Cells in Chronic Lymphocytic Leukemia and Their Therapeutic Implications |
| Q64085662 | Molecular pathogenic pathways in extranodal NK/T cell lymphoma |
| Q47113074 | Natural autophagy blockers, dauricine (DAC) and daurisoline (DAS), sensitize cancer cells to camptothecin-induced toxicity |
| Q64921129 | Nutrient deprivation and lysosomal stress induce activation of TFEB in retinal pigment epithelial cells. |
| Q91826055 | Oncogenic seRNA functional activation: a novel mechanism of tumorigenesis |
| Q99709271 | Positron Emission Tomography for Response Evaluation in Microenvironment-Targeted Anti-Cancer Therapy |
| Q52348330 | Programmed Cell Death, from a Cancer Perspective: An Overview. |
| Q64968549 | ROS-mediated activation and mitochondrial translocation of CaMKII contributes to Drp1-dependent mitochondrial fission and apoptosis in triple-negative breast cancer cells by isorhamnetin and chloroquine. |
| Q89956053 | Small-molecule drug repurposing to target DNA damage repair and response pathways |
| Q41479802 | Stat3 as a potential therapeutic target for rheumatoid arthritis. |
| Q58595915 | Study on Cardiotoxicity and Mechanism of "Fuzi" Extracts Based on Metabonomics |
| Q89682949 | Targeting Cancer Metabolism to Resensitize Chemotherapy: Potential Development of Cancer Chemosensitizers from Traditional Chinese Medicines |
| Q47705533 | Targeting autophagy in lymphomas: a double-edged sword? |
| Q51748509 | The In Vitro Effects of Enzymatic Digested Gliadin on the Functionality of the Autophagy Process. |
| Q92704558 | The Switch between Protective and Nonprotective Autophagy; Implications for Autophagy Inhibition as a Therapeutic Strategy in Cancer |
| Q64889033 | The anticancer effects of ferulic acid is associated with induction of cell cycle arrest and autophagy in cervical cancer cells. |
| Q42654753 | The crosstalk between autophagic and endo-/exosomal pathways in antigen processing for MHC presentation in anticancer T cell immune responses |
| Q92463694 | The crosstalk between autophagy and ferroptosis: what can we learn to target drug resistance in cancer? |
| Q64282716 | The roles of glucose metabolic reprogramming in chemo- and radio-resistance |
| Q99237920 | Uncovering the Mechanisms of Cryptotanshinone as a Therapeutic Agent Against Hepatocellular Carcinoma |
| Q57068029 | extract induces apoptosis and suppresses autophagy through ERK activation in lung cancer cells |
| Q55413938 | miR-519a enhances chemosensitivity and promotes autophagy in glioblastoma by targeting STAT3/Bcl2 signaling pathway. |
| Q92582229 | p53 mediates PEDF‑induced autophagy in human umbilical vein endothelial cells through sestrin2 signaling |
Search more.